These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38222169)

  • 1. Tamsulosin Versus Mirabegron in Relieving Ureteric Stent-Related Symptoms: A Prospective, Double-Blinded, Randomized Controlled Trial.
    Javid M; Abdullah A; Ganapathy R; Gupta YB; Selvaraj S; Ilangovan AK; Sivalingam S; Prasad S
    Cureus; 2023 Dec; 15(12):e50502. PubMed ID: 38222169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Mirabegron plus Tamsulosin and Tamsulosin Monotherapy for the Treatment of Ureteral Stent-Related Symptoms: A Prospective Randomized Study.
    Zhang K; Yan W; Li H; Chen J; Wang Q; Chai Y; Yuan L; Zhu G
    Urol Int; 2022; 106(12):1226-1232. PubMed ID: 36244331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does mirabegron relieve ureteric stent-related discomfort? A prospective, randomized, multicentre study.
    Tae BS; Cho S; Jeon BJ; Choi H; Park JY; Cho SY; Lee KC; Bae JH
    BJU Int; 2018 Nov; 122(5):866-872. PubMed ID: 29802800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of stent related symptoms in patients taking mirabegron, solifenacin, or tamsulosin: A double blinded randomized clinical trial.
    Chandna A; Kumar S; Parmar KM; Sharma AP; Devana SK; Mete UK; Singh SK
    Urologia; 2022 Nov; 89(4):589-596. PubMed ID: 34596484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does tamsulosin or mirabegron improve ureteral stent-related symptoms? A prospective placebo-controlled study.
    Yavuz A; Kilinc MF; Aydin M; Ofluoglu Y; Bayar G
    Low Urin Tract Symptoms; 2021 Jan; 13(1):17-21. PubMed ID: 32408390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of tamsulosin hydrochloride in relieving "double-J ureteral stent-related morbidity": a randomized placebo controlled clinical study.
    Singh I; Tripathy S; Agrawal V
    Int Urol Nephrol; 2014 Dec; 46(12):2279-83. PubMed ID: 25201459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of ureteral catheter related symptoms; mirabegron versus tamsulosin/solifenacin combination: A randomized controlled trial.
    Sahin A; Yildirim C; Yuksel OH; Urkmez A
    Arch Esp Urol; 2020 Jan; 73(1):54-59. PubMed ID: 31950924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis showing the beneficial effect of α-blockers on ureteric stent discomfort.
    Lamb AD; Vowler SL; Johnston R; Dunn N; Wiseman OJ
    BJU Int; 2011 Dec; 108(11):1894-902. PubMed ID: 21453351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of specific alpha-1A/1D blocker on lower urinary tract symptoms due to double-J stent: a prospectively randomized study.
    Wang CJ; Huang SW; Chang CH
    Urol Res; 2009 Jun; 37(3):147-52. PubMed ID: 19277623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled trial comparing alpha blocker (tamsulosin) and anticholinergic (solifenacin) in treatment of ureteral stent-related symptoms.
    El-Nahas AR; Tharwat M; Elsaadany M; Mosbah A; Gaballah MA
    World J Urol; 2016 Jul; 34(7):963-8. PubMed ID: 26453222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of tamsulosin oral-controlled absorption system, solifenacin, and combined therapy for the management of ureteric stent-related symptoms.
    Abdelaal AM; Al-Adl AM; Abdelbaki SA; Al Azab MM; Al Gamal KA
    Arab J Urol; 2016 Jun; 14(2):115-22. PubMed ID: 27489738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of efficacy and tolerance of short-duration open-ended ureteral catheter drainage and tamsulosin administration to indwelling double J stents following ureteroscopic removal of stones.
    Chauhan VS; Bansal R; Ahuja M
    Hong Kong Med J; 2015 Apr; 21(2):124-30. PubMed ID: 25756274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Approaches in Treating Double-J Stent Syndrome: Monotherapy or Combination Therapy?
    Pricop C; Bandac CA; Ivanuță M; Rădăvoi D; Jinga V; Puia D
    J Clin Med; 2024 Jul; 13(14):. PubMed ID: 39064317
    [No Abstract]   [Full Text] [Related]  

  • 14. Mirabegron for the Treatment of Ureteral Stent-related Symptoms: A Systematic Review and Meta-analysis.
    Van Besien J; Keller EX; Somani B; Pietropaolo A; Claessens M; Merckx L; Tailly T; De Coninck V
    Eur Urol Focus; 2022 Jul; 8(4):1031-1041. PubMed ID: 34688588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing efficacy and safety of mirabegron, tamsulosin, and solifenacin in ureteral stent-related symptoms: outcomes from a network meta-analysis.
    Xiang N; Hu Y; Peng W; Luo M; Yang Y; Zhang Q
    Transl Androl Urol; 2024 May; 13(5):699-707. PubMed ID: 38855609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does Combination Therapy with Tamsulosin and Tolterodine Improve Ureteral Stent Discomfort Compared with Tamsulosin Alone? A Double-Blind, Randomized, Controlled Trial.
    Sivalingam S; Streeper NM; Sehgal PD; Sninsky BC; Best SL; Nakada SY
    J Urol; 2016 Feb; 195(2):385-90. PubMed ID: 26393904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mirabegron Add-on Therapy to Tamsulosin for the Treatment of Overactive Bladder in Men with Lower Urinary Tract Symptoms: A Randomized, Placebo-controlled Study (MATCH).
    Kakizaki H; Lee KS; Yamamoto O; Jong JJ; Katou D; Sumarsono B; Uno S; Yamaguchi O
    Eur Urol Focus; 2020 Jul; 6(4):729-737. PubMed ID: 31718957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamsulosin, Solifenacin, and Their Combination for the Treatment of Stent-Related Symptoms: A Randomized Controlled Study.
    Dellis AE; Papatsoris AG; Keeley FX; Bamias A; Deliveliotis C; Skolarikos AA
    J Endourol; 2017 Jan; 31(1):100-109. PubMed ID: 27809592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of highly concentrated hyaluronic acid/chondroitin sulphate instillation on ureteric stent-induced discomfort after ureteroscopic lithotripsy: a multicentre randomised controlled pilot study.
    Jo JK; Kim JH; Kim KS; Chung JH; Kim YT; Choi HY; Song ES; Lee B; Lee SW
    BJU Int; 2018 Nov; 122(5):858-865. PubMed ID: 29772114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Tamsulosin, Oxybutynin, and their combination in the control of double-j stent-related lower urinary tract symptoms.
    Maldonado-Avila M; Garduno-Arteaga L; Jungfermann-Guzman R; Manzanilla-Garcia HA; Rosas-Nava E; Procuna-Hernandez N; Vela-Mollinedo A; Almazan-Trevino L; Guzman-Esquivel J
    Int Braz J Urol; 2016; 42(3):487-93. PubMed ID: 27286111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.